CareDx, Inc vs Dr. Lal Path Labs Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Dr. Lal Path Labs Ltd. is the larger company by market value: $3.6 B against $3.4 B for CareDx, Inc, 1.1 times as much (market caps of Oct 19, 2026 for CareDx, Inc and Nov 20, 2026 for Dr. Lal Path Labs Ltd.).
- CareDx, Inc had more revenue: $380 M in the year to December 2025 against $261 M for Dr. Lal Path Labs Ltd. in the year to March 2022.
- Dr. Lal Path Labs Ltd. made a net profit of $43 M, while CareDx, Inc made a net loss of $21 M.
- Dr. Lal Path Labs Ltd. keeps more of each dollar of sales: a net margin of 16.5% against -5.6% for CareDx, Inc.
- Dr. Lal Path Labs Ltd. employs more people: 3,923 against 645 at CareDx, Inc. Each employee brings in about $588,837 of revenue at CareDx, Inc and $66,531 at Dr. Lal Path Labs Ltd.
- On price to earnings, Dr. Lal Path Labs Ltd. trades at 84.5× and CareDx, Inc at 26.1×: investors pay more for each dollar of Dr. Lal Path Labs Ltd.'s profit.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | CareDx, Inc CDNA · #4,671 in the world | Dr. Lal Path Labs Ltd. LALPATHLAB.NS · #4,436 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇮🇳 India |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1998 | 1949 |
| Size | ||
| Market cap | $3.4 B | $3.6 B |
| Revenue | $380 M | $261 M |
| Net income | $-21 M | $43 M▲ best |
| Employees | 645 | 3,923 |
| Valuation | ||
| P/E ratio | 26.1× | 84.5× |
| Price to sales | 6.8× | 13.9× |
| Price to book | 11.1× | 18.8× |
| Free cash flow yield | -0.2% | — |
| Profitability | ||
| Operating margin | -8.1% | — |
| Net margin | -5.6% | — |
| Return on equity | -6.3% | — |
| Growth | ||
| Revenue growth | 13.8% | — |
| Revenue growth, 3 years a year | 5.7% | — |
| Shareholder returns | ||
| Shareholder yield | 2.6% | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Nov 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, CareDx, Inc or Dr. Lal Path Labs Ltd.?
Dr. Lal Path Labs Ltd. is the larger company by market value: $3.6 B against $3.4 B for CareDx, Inc, 1.1 times as much (market caps of Oct 19, 2026 for CareDx, Inc and Nov 20, 2026 for Dr. Lal Path Labs Ltd.).
Which makes more money, CareDx, Inc or Dr. Lal Path Labs Ltd.?
CareDx, Inc had more revenue: $380 M in the year to December 2025 against $261 M for Dr. Lal Path Labs Ltd. in the year to March 2022. Dr. Lal Path Labs Ltd. made a net profit of $43 M, while CareDx, Inc made a net loss of $21 M.
Which is more profitable, CareDx, Inc or Dr. Lal Path Labs Ltd.?
Dr. Lal Path Labs Ltd. keeps more of each dollar of sales: a net margin of 16.5% against -5.6% for CareDx, Inc.
Which has more employees, CareDx, Inc or Dr. Lal Path Labs Ltd.?
Dr. Lal Path Labs Ltd. employs more people: 3,923 against 645 at CareDx, Inc. Each employee brings in about $588,837 of revenue at CareDx, Inc and $66,531 at Dr. Lal Path Labs Ltd.
Is CareDx, Inc cheaper than Dr. Lal Path Labs Ltd.?
On price to earnings, Dr. Lal Path Labs Ltd. trades at 84.5× and CareDx, Inc at 26.1×: investors pay more for each dollar of Dr. Lal Path Labs Ltd.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
More about CareDx, Inc
More about Dr. Lal Path Labs Ltd.
Sources#
Every figure on this page comes from these, with the date shown next to it.